Skip to Content

BMS 300 mg 3622 (Reyataz 300 mg)

Generic Name: atazanavir

Pill with imprint BMS 300 mg 3622 is Red / Blue, Capsule-shape and has been identified as Reyataz 300 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 300 mg 3622

Reyataz 300 mg BMS 300 mg 3622
Reyataz 300 mg BMS 300 mg 3622
Reyataz 300 mg BMS 300 mg 3622
Reyataz 300 mg BMS 300 mg 3622

Reyataz

Generic Name
atazanavir
Imprint
BMS 300 mg 3622
Strength
300 mg
Color
Red / Blue
Size
23.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
Inactive Ingredients
lactose monohydrate, magnesium stearate, FD&C Blue No. 2, titanium dioxide, ferric oxide red, ferric oxide yellow, isopropyl alcohol, ammonia, propylene glycol, butyl alcohol, alcohol, ferrosoferric oxide, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00003-3622
54569-5864 A-S Medication Solutions, LLC (repackager)
54868-5838 Physicians Total Care Inc. (repackager)
35356-0114 Lake Erie Medical and Surgical Supply (repackager)

Get help with Imprint Code FAQs.

Related Images for "BMS 300 mg 3622"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.